Personalizing anticancer therapy therefore relies upon identifying each patient's cancer-specific driver mutations. Although routine analysis of cancer genomes using NGS is an aim for the short to ...
The companion diagnostic tests in oncology market is experiencing rapid growth as precision medicine becomes a cornerstone of cancer treatment. These diagnostic tools are designed to identify specific ...
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Nintendo tends to introduce wholly new consoles that build on the features and power of ...
A major drawback, especially with regard to leukemia diagnostics and minor cell populations, is that it can only reliably identify mutations ... and next-generation sequencing techniques are ...
Nifty Next 50 represents the next set of 50 large-cap and mid-cap companies after Nifty 50, providing a broader perspective on the Indian equity market's performance and trends.